ESC 365 - Should diabetes influence antithrombotic therapy decision-making?

ESC Premium Access

Should diabetes influence antithrombotic therapy decision-making?

Session: Personalised management of patients with diabetes and coronary artery disease: unresolved issues

Topic: Treatment

Speaker: Professor P. Gurbel (Baltimore, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Paul Gurbel

Sinai Hospital, Baltimore (United States of America)

1 presentation

0 follower

4 more presentations in this session

Glycaemic control in a patient with acute coronary syndrome: how and how much

Speaker: Doctor A. Sambola (Barcelona, ES)

Surgical vs. percutaneous revascularisation in multi-vessel disease

Speaker: Professor M. Ruel (Ottawa, CA)

Anti-diabetes therapy beyond glycaemic control

Speaker: Professor K. Marx-Schuett (Aachen, DE)

Personalised management of patients with diabetes and coronary artery disease: unresolved issues - discussion

Access the full session

Personalised management of patients with diabetes and coronary artery disease: unresolved issues

Speakers: Professor P. Gurbel, Doctor A. Sambola, Professor M. Ruel, Professor K. Marx-Schuett

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources